Bionovate Technologies Corp carries a market capitalization of 775.00, placing it among publicly traded companies globally.
| Market Cap | 775.00 |
| Enterprise Value | N/A |
Bionovate Technologies Corp currently has 7.75M shares outstanding.
| Shares Outstanding | 7.75M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| Current Ratio | N/A |
| Quick Ratio | N/A |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -0.84 |
Bionovate Technologies Corp's stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
EBITDA reached -48,028.00, while operating income came in at -48,028.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -48,028.00 |
| Pretax Income | -105,306.00 |
| Net Income | -105,306.00 |
| EBITDA | -48,028.00 |
| EBIT | -48,028.00 |
| Earnings Per Share (EPS) | 0.00 |
Total book value stands at -2.83M, with working capital of -524,845.00 providing operational flexibility.
| Cash & Cash Equivalents | N/A |
| Total Debt | N/A |
| Net Debt | 237,528.00 |
| Equity (Book Value) | -2.83M |
| Book Value Per Share | -0.08 |
| Working Capital | -524,845.00 |
Bionovate Technologies Corp's most recent stock split took place on January 9, 2020 with a 100:1 split ratio.
| Last Split Date | 1/9/2020 |
| Split Ratio | 100:1 |